CMH Multan Institute of Medical Sciences
Multan, Punjab Province, 60000, Pakistan
NCT Number: NCT07379762
The goal of this clinical study is to find out which way of giving diclofenac sodium provides better pain relief after a planned cesarean section: an injection into the muscle or a suppository given through the rectum. Diclofenac is a commonly used pain-relieving medicine after surgery.
Women often experience moderate pain after a cesarean section, and effective pain control helps with early movement, breastfeeding, and overall recovery. Different methods of giving the same medicine may work differently and may affect how comfortable patients feel after surgery. This study compares these two methods to see which one reduces pain more effectively.
Researchers will compare post-operative pain levels in women who receive intramuscular diclofenac with those who receive rectal diclofenac after elective cesarean section.
The main questions this study aims to answer are:
* Does intramuscular diclofenac provide better pain relief than rectal diclofenac after cesarean section? * Is there a difference in the need for additional (rescue) pain medicine between the two groups?
Participants will be women aged 20 to 45 years who are undergoing a planned cesarean section at term. A total of 60 women will take part in the study. They will be randomly assigned to one of two groups:
* One group will receive diclofenac as an intramuscular injection every 8 hours for the first 24 hours after surgery. * The other group will receive diclofenac as a rectal suppository every 8 hours for the same period.
All participants will receive standard spinal anesthesia for surgery. Pain will be measured using a simple pain scale at 1, 6, 12, and 24 hours after the operation. If a participant reports significant pain, additional pain medicine will be given.
The results of this study will help doctors choose the most effective and comfortable method of pain relief for women after cesarean section.
Looking for future studies?
Notify Me20 year–45 year
Female
Interventional
Phase 4
Multan, Punjab Province, 60000, Pakistan
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Participants will be given intramuscular diclofenac 75mg 8hourly for first 24-hours after cesarean section
Other names: Diclofenac sodium, Voltarol
Participants will be given diclofenac suppository every 8 hours for first 24-hours after cesarean section
Time frame: Pain will be assessed at 1, 6, 12 and 24-hours after cesarean section
Pain will be assessed on visual analog scale by the blinded assessor
Time frame: From cesarean section to 24-hours postoperatively
In cases of VAS > 4, extra analgesia (rescue analgesia) will be given to control pain
CMH Multan Institute of Medical Sciences
Other Gov
Comparison of Intramuscular Versus Rectal Diclofenac Sodium in Post Caesarean Pain Relief
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07718360
Cesarean Section Pain, Neurologic Manifestations
Islamabad, Federal Capital Territory, Pakistan
View Trial DetailsNCT07022821
Cesarean Section Pain, Neurologic Manifestations
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT05276206
Cesarean Section Pain, Neurologic Manifestations
Cairo, Egypt
View Trial DetailsNCT07551401
Cesarean Section, Cesarean Section Pain
Konya, Turkey (Türkiye)
View Trial Details